Short communication: Viremic control is independent of repeated low-dose SHIVSF162p3 exposures

AIDS Research and Human Retroviruses

Volumn 30, Issue 11, 2014, Pages 1125-1129

  Henning, Tara R ^a   Hanson, Debra ^a   Vishwanathan, Sundaram A ^a   Butler, Katherine ^a   Dobard, Charles ^a   Garcia Lerma, Gerardo ^a   Radzio, Jessica ^a   Smith, James ^a   McNicholl, Janet M ^a   Kersh, Ellen N ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS RNA;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; AREA UNDER THE CURVE; ARTICLE; CONTROLLED STUDY; DISEASE MARKER; FEMALE; INOCULATION; LENTIVIRINAE; MACACA NEMESTRINA; MALE; NONHUMAN; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; RETROSPECTIVE STUDY; RHESUS MONKEY; SIMIAN ACQUIRED IMMUNODEFICIENCY SYNDROME; SIMIAN ACQUIRED IMMUNODEFICIENCY VIRUS; VIREMIA; VIRUS LOAD; ANIMAL; BLOOD; COHORT ANALYSIS; DISEASE MODEL; HUMAN IMMUNODEFICIENCY VIRUS; IMMUNOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIMIAN IMMUNODEFICIENCY VIRUS; VIROLOGY;

ANIMALS; COHORT STUDIES; DISEASE MODELS, ANIMAL; FEMALE; HIV; MACACA MULATTA; MACACA NEMESTRINA; MALE; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, VIRAL; SIMIAN ACQUIRED IMMUNODEFICIENCY SYNDROME; SIMIAN IMMUNODEFICIENCY VIRUS; VIRAL LOAD;

EID: 84928559014     PISSN: 08892229     EISSN: 19318405     Source Type: Journal    
DOI: 10.1089/aid.2014.0238     Document Type: Article

References (23)

1. Fowke KR, Nagelkerke NJ, Kimani J, et al.: Resistance to HIV-1 infection among persistently seronegative prostitutes in Nairobi, Kenya. Lancet 1996;348(9038):1347-1351.
2. Kaul R, Rowland-Jones SL, Kimani J, et al.: New insights into HIV-1 specific cytotoxic T-lymphocyte responses in exposed, persistently seronegative Kenyan sex workers. Immunol Lett 2001;79(1-2):3-13.
3. Abdulhaqq SA, Martinez MI, Kang G, et al.: Serial cervi-covaginal exposures with replication-deficient SIVsm induce higher dendritic cell (pDC) and CD4+ T-cell infiltrates not associated with prevention but a more severe SIVmac251 infection of rhesus macaques. J Acquir Immune Defic Syndr 2014;65(4):405-413.
4. Kirmaier A, Wu F, Newman RM, et al.: TRIM5 suppresses cross-species transmission of a primate immunodeficiency virus and selects for emergence of resistant variants in the new species. PLoS Biol 2010;8(8):e1000462.
5. Kersh EN, Luo W, Adams DR, et al.: Repeated rectal SHIVSF162P3 exposures do not consistently induce sustained T cell responses prior to systemic infection in the repeat-low dose preclinical macaque model. AIDS Res Hum Retroviruses 2009;25(9):905-917.
6. Letvin NL, Rao SS, Dang V, et al.: No evidence for consistent virus-specific immunity in simian immunodeficiency virus-exposed, uninfected rhesus monkeys. J Virol 2007; 81(22):12368-12374.
7. Ma ZM, Abel K, Rourke T, et al.: A period of transient viremia and occult infection precedes persistent viremia and antiviral immune responses during multiple low-dose intravaginal simian immunodeficiency virus inoculations. J Virol 2004;78(24):14048-14052.
8. McDermott AB, Mitchen J, Piaskowski S, et al.: Repeated low-dose mucosal simian immunodeficiency virus SIV-mac239 challenge results in the same viral and immuno-logical kinetics as high-dose challenge: A model for the evaluation of vaccine efficacy in nonhuman primates. J Virol 2004;78(6):3140-3144.
9. Promadej-Lanier N, Srinivasan P, Curtis K, et al.: Systemic and mucosal immunological responses during repeated mucosal SHIV(162P3) challenges prior to and following infection in pigtailed macaques. Virology 2008;375(2): 492-503.
10. Trivedi P, Horejsh D, Hinds SB, et al.: Intrarectal transmission of simian immunodeficiency virus in rhesus macaques: Selective amplification and host responses to transient or persistent viremia. J Virol 1996;70(10):6876-6883.
11. Harouse JM, Gettie A, Tan RC, et al.: Distinct pathogenic sequela in rhesus macaques infected with CCR5 or CXCR4 utilizing SHIVs. Science 1999;284(5415):816-819.
12. Aidoo M, Otten RA, Rodriguez V, et al.: Absence of SHIV infection in gut and lymph node tissues in rhesus monkeys after repeated rectal challenges following HIV-1 DNA/MVA immunizations. Vaccine 2007;25(35):6474-6481.
13. Butler K, Morgan JS, Hanson DL, et al.: Susceptibility to repeated, low-dose, rectal SHIVSF162P3 challenge is independent of TRIM5 genotype in rhesus macaques. AIDS Res Hum Retroviruses 2013;29(7):1091-1094.
14. Dobard C, Sharma S, Parikh UM, et al.: Postexposure protection of macaques from vaginal SHIV infection by topical integrase inhibitors. Sci Transl Med 2014;6(227): 227ra235.
15. Kersh EN, Luo W, Adams DR, et al.: Short communication: No evidence of occult SHIV infection as demonstrated by CD8 + cell depletion after chemoprophylaxis-induced protection from mucosal infection in rhesus macaques. AIDS Res Hum Retroviruses 2008;24(4):543-546.
16. Otten RA, Adams DR, Kim CN, et al.: Multiple vaginal exposures to low doses of R5 simian-human immunodeficiency virus: Strategy to study HIV preclinical interventions in nonhuman primates. J Infect Dis 2005;191(2): 164-173.
17. Parikh UM, Dobard C, Sharma S, et al.: Complete protection from repeated vaginal simian-human immunodeficiency virus exposures in macaques by a topical gel containing tenofovir alone or with emtricitabine. J Virol 2009;83(20):10358-10365.
18. Radzio J, Aung W, Holder A, et al.: Prevention of vaginal SHIV transmission in macaques by a coitally-dependent Truvada regimen. PLoS One 2012;7(12):e50632.
19. Smith JM, Rastogi R, Teller RS, et al.: Intravaginal ring eluting tenofovir disoproxil fumarate completely protects macaques from multiple vaginal simian-HIV challenges. Proc Natl Acad Sci USA 2013;110(40): 16145-16150.
20. Regoes RR: The role of exposure history on HIV acquisition: Insights from repeated low-dose challenge studies. PLoS Comput Biol 2012;8(11):e1002767.
21. Harouse JM, Gettie A, Eshetu T, et al.: Mucosal transmission and induction of simian AIDS by CCR5-specific simian/human immunodeficiency virus SHIV(SF162P3). J Virol 2001;75(4):1990-1995.
22. Kersh EN, Luo W, Zheng Q, et al.: Reduced inflammation and CD4 loss in acute SHIV infection during oral pre-exposure prophylaxis. J Infect Dis 2012;206(5):770-779.
23. Pahar B, Wang X, Dufour J, et al.: Virus-specific T cell responses in macaques acutely infected with SHIV(sf162p3). Virology 2007;363(1):36-47.